Business UpdateJun 26, 2026, 04:02 PM
Ascendis Pharma Added to Russell 3000, 1000, 2500, and Midcap Indexes
AI Summary
Ascendis Pharma A/S announced its inclusion in several prominent Russell U.S. Indexes, effective June 26, 2026. The company has been added to the broad-market Russell 3000® Index, the large-cap Russell 1000® Index, the small-to-mid-cap Russell 2500® Index, and the Russell Midcap® Index. This inclusion is part of the 2026 Russell U.S. Indexes semi-annual reconstitution and is expected to increase the company's visibility among institutional investors.
Key Highlights
- Ascendis Pharma added to the Russell 3000® Index.
- Company also included in the Russell 1000® Index.
- Inclusion in the Russell 2500® Index and Russell Midcap® Index.
- Effective at the close of U.S. equity markets on June 26, 2026.
- Russell U.S. Indexes are widely used by investment managers and institutional investors.
- Approximately $11.8 trillion in assets are benchmarked against Russell U.S. Indexes as of Dec 31, 2024.
Price Impact
More from ASND